The Bio Report cover image

Beefing Up Computational Muscle to Understand Molecular Activity of Drug Candidates

The Bio Report

00:00

Introduction

This chapter discusses recent clinical study failures tied to randomization and supply logistics, as well as the rise of dosing data inconsistencies between vendors. It also features an interview with Sandbox AQ's general manager, Nadia Herron, on their use of quantum technologies in drug development and their recent acquisition of Good Chemistry.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app